Navigation Links
Bovine Serum, Adult from Sigma-Aldrich
MitoPT-25:MITOCHONDRIAL PERMEABILITY TRANSITION KIT from AbD Serotec
Rabbit Anti-Human DDX5 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Human phospho-RTKs Antibody array Assay Kit from R&D Systems
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
Biology Products:
(Date:12/4/2009)...ging accepted thinking about amyloids the fibrous... Alzheimer,s and Parkinson,s and may open up a po...eved that amyloid fibrils - rope-like structures m... inert, but that there may be toxic phases during ...isease. , But in a paper published today [04 De...
(Date:12/3/2009)... BIO-key International, ...ess public safety and finger-based biometric ident...its shareholders at a Special Shareholder Meeting ...Enforcement Division to Interact911 Mobile Systems...r and 1.2% were opposed. ,, (Logo: http://www....
(Date:12/3/2009)...n and his co-workers discovered that specific type...cer. Scientists soon found out how these pathogens... the main culprits are viral proteins E6 and E7. B... functions, thus promoting cell growth. , Profe... now discovered another mechanism by which the E6 ...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Papillomavirus silences innate immune response 2Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 1Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 2Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 3Global Jatropha Hi Tech Agricultural Training Programme 28JWTP 29 13319 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5New national study finds increase in P E class related injuries 53440 1New national study finds increase in P E class related injuries 53440 2
... A team of scientists at the Genome Institute of ...n city-state,s Agency for Science, Technology and ...a at San Francisco have developed a pharmacologica... and epigenetic defects in the signaling of a prot...d to be abnormally activated in human malignance, ...
... Using the same concept behind commercial breath... has developed a new, easier method for clinical t...oratory of Gustatory Psychophysics in the Biology ...nology ( http://www.temple.edu/biology ), has crea...ps, but these edible strips contain one of the fiv...
... WESTCHESTER, Ill. Total fat intake and dinner f...attern in healthy adults, according to a research ...P 2008, the 22nd Annual Meeting of the Associated ... authored by Cibele Crispim, of the Federal Univer... volunteers between 20-45 years of age, whose food...
Other Biology News:Taking a cue from breath fresheners, researcher develops new method for taste testing 2Taking a cue from breath fresheners, researcher develops new method for taste testing 3Fat intake negatively influences the sleep pattern in healthy adults 2
(Date:12/4/2009)...RNewswire-FirstCall/ -- BlueFire Ethanol Fuels, In...n changing the world,s transportation fuel paradig...cellulosic wastes, has been ranked number 19 on th...ies in Bioenergy;" the company,s second consecutiv...lueFire Ethanol among the top 20 bioenergy compani...
(Date:12/3/2009)...swire/ -- JourneyLite of Houston, LLC announced ...tients a second surgical option, vertical sleeve ...m that it currently performs. The first sleeve ga...by surgeon partner, Matthew St. Laurent, MD on O...well. ,, The Vertical Sleeve Gastrectomy (also ...
(Date:12/3/2009)...Newswire/ -- Nikon Corporation, an innovator of ad...t has signed a licensing agreement with Harvard Un...hastic Optical Reconstruction Microscopy (STORM) t... will manufacture STORM enabled microscopy systems...on Corporation President, Mr. Michio Kariya, and N...
(Date:12/3/2009)...swire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.... update on its European commercial launch of MuGar... debilitating side effect of radiation treatment a...y Access, partner, SpePharm, in six European count...eece and Sweden. Access is conducting pre-marketin...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4